Disparities in participation in cancer clinical trials in the United States : A symptom of a healthcare system in crisis
β Scribed by Gerardo Colon-Otero; Robert C. Smallridge; Lawrence A. Solberg Jr; Thomas D. Keith; Timothy A. Woodward; Floyd B. Willis; Ajani N. Dunn
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 234 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Disparities in minorities' representation in cancer clinical trials have been shown only in adult populations, which suggest that the main causes of these disparities relate to health systemβbased barriers, including issues of poverty (lack of insurance), poor access to trials, and an inadequate number of clinical trials. Initiatives that increase the participation of community physicians in cancer clinical research trials and increase low socioeconomic status patients' access to cancer trials will likely ameliorate this problem. Cancer 2008. Β© 2007 American Cancer Society.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Underrepresentation of older patients in cancer clinical trials has been reported previously. ## METHODS. To evaluate disparities in age between actual cancer patients and those enrolled in clinical trials, the authors examined all the review reports of the Pharmaceuti
## BACKGROUND. After injuries, cancer is the leading cause of death in children younger than 15 years in the IJnited States. Despite dramatic increases in .?-year survival rates, more than 100,000 person-years of life are lost to childhood cancer each year. 'The exact proportion of pediatric cance
## Background: African-american patients have been under-represented in oncology clinical trials. better understanding barriers to african-american participation may help increase the accrual of african-american patients onto clinical trials. ## Methods: Two hundred eighteen patients with maligna
## Abstract ## BACKGROUND. Parathyroid cancer is a rare cause of hyperparathyroidism. The objectives of this study were to determine the patterns of disease, treatment trends, and outcomes among patients with parathyroid cancer by using a populationβbased data source. ## METHODS. Surveillance, E